
### [NCIT:C5629](http://purl.obolibrary.org/obo/NCIT_C5629)
**Label:** Metastatic Malignant Neoplasm in the Skin

**Subclasses:** [NCIT:C28311](http://purl.obolibrary.org/obo/NCIT_C28311) (Breast Carcinoma Metastatic in the Skin), [NCIT:C5628](http://purl.obolibrary.org/obo/NCIT_C5628) (Carcinoma Metastatic in the Skin), 

**Class expressions from DL-Learner:**

- [UBERON:0002097](http://purl.obolibrary.org/obo/UBERON_0002097) (skin of body) 60.00%
- [NCIT:C41444](http://purl.obolibrary.org/obo/NCIT_C41444) (Secondary Lesion) 60.00%
- [NCIT:C40557](http://purl.obolibrary.org/obo/NCIT_C40557) (Metastatic Lesion) 60.00%
- [NCIT:C36156](http://purl.obolibrary.org/obo/NCIT_C36156) (Favorable Clinical Outcome) 60.00%
- Thing 51.79%
- [NCIT:C3367](http://purl.obolibrary.org/obo/NCIT_C3367) (Finding) 33.10%
- [NCIT:C7057](http://purl.obolibrary.org/obo/NCIT_C7057) (Disease, Disorder or Finding) 32.64%
- [NCIT:C3824](http://purl.obolibrary.org/obo/NCIT_C3824) (Lesion) 28.91%
- [NCIT:C35461](http://purl.obolibrary.org/obo/NCIT_C35461) (Clinical Course of Disease) 18.70%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) 13.24%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 12.48%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 12.37%
- [BFO:0000040](http://purl.obolibrary.org/obo/BFO_0000040) (material entity) 11.52%
- [UBERON:0001062](http://purl.obolibrary.org/obo/UBERON_0001062) (anatomical entity) 11.52%
- [BFO:0000004](http://purl.obolibrary.org/obo/BFO_0000004) (null) 11.42%


